Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2026-04-19 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
祥生医疗第三届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the third board of directors of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes approvals of the 2025 annual report text and summary, the 2025 board work report, the 2025 general manager work report, profit distribution plans, internal control evaluation report, and other governance and financial matters. The document repeatedly states that these matters will be submitted to the 2025 annual shareholders meeting for approval. It also references multiple related announcements published separately on the Shanghai Stock Exchange website, indicating that this document itself is a board meeting resolution announcement rather than the full annual report or other reports. The document is over 5,000 characters and contains substantive content about board decisions and approvals, which fits the category of Board/Management Information (MANG). It is not a full annual report (10-K) or an earnings release (ER), nor is it a report publication announcement (RPA) because it contains detailed meeting resolutions rather than just a notice of report availability. Therefore, the correct classification is MANG with high confidence.
2026-04-19 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司使用部分暂时闲置募集资金及自有资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (Guojin Securities Co., Ltd.) regarding the use of temporarily idle raised funds and own funds by Wuxi Xiangsheng Medical Technology Co., Ltd. for cash management. It references regulatory guidelines related to the management and use of raised funds, details the amounts, investment types, risk controls, and approvals by the board and audit committee. The document is not a full financial report but a formal verification opinion on a specific financial management activity related to raised funds. It is not an announcement of a report publication, nor a certification letter. It fits best under Audit Report / Information (AR) as it is a standalone audit/verification opinion on the use of funds, including compliance with regulatory requirements and internal controls, but not a full annual or interim report. Q2 2026
2026-04-19 Chinese
祥生医疗关于使用部分暂时闲置募集资金及自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the use of temporarily idle raised funds and own funds for cash management. It includes specifics about the types of cash management products, amounts, approval procedures, risk analysis, and opinions from independent directors, audit committee, and the sponsoring institution. The document is a formal disclosure about the company's financing and cash management activities, not a financial report or earnings release. It does not contain financial statements or quarterly/yearly results but focuses on capital management and regulatory compliance related to the use of funds. This fits the definition of a Capital/Financing Update (CAP).
2026-04-19 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司2025年度募集资金存放、管理与实际使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from the sponsor institution (国金证券股份有限公司) regarding the 2025 annual verification of the storage, management, and actual use of funds raised by 无锡祥生医疗科技股份有限公司 from its initial public offering in 2019. It includes extensive financial data on the amount raised, usage, cash management, project progress, and compliance with regulatory requirements. The document references regulatory guidelines related to fundraising and fund management, and includes an auditor's verification opinion. The content focuses specifically on the management and use of raised capital funds for the year 2025, which aligns with the definition of an Audit Report / Information (AR) as it is a standalone audit and verification report on fundraising usage, not a full annual report or earnings release. The document length is over 11,000 characters and contains substantive financial and management information about fundraising usage, not merely an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2025
2026-04-19 Chinese
祥生医疗关于召开2025年年度股东会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of Wuxi Xiangsheng Medical Technology Co., Ltd., including the date, voting methods, agenda items, and procedural details. It does not contain the actual annual report or financial statements but rather the announcement and information related to the upcoming AGM. The document length is 3695 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on meeting logistics, agenda, and voting instructions, which aligns with the definition of AGM Information (AGM-R).
2026-04-19 Chinese
无锡祥生医疗科技股份有限公司2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled "无锡祥生医疗科技股份有限公司2025年年度报告摘要" which translates to "Wuxi Chison Medical Technology Co., Ltd. 2025 Annual Report Summary." It contains detailed information about the company's business, products, industry background, market size, technology, and future outlook. It includes financial data such as dividend distribution plans and audit opinions. The document is lengthy (15,000 characters) and contains substantive financial and operational data typical of an annual report. It is not merely an announcement or a presentation but a comprehensive summary of the annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.